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POTENTIAL UTILITY OF HYPERBARIC OXYGEN THERAPY AND PROPOLIS IN ENHANCING THE 
LEISHMANICIDAL ACTIVITY OF GLUCANTIME
Diana Copi AYRES(1), Thiago Antonio FEDELE(2), Maria Cristina MARCUCCI(2) & Selma GIORGIO(1)
SUMMARY
In this study we investigated the efficacy of hyperbaric oxygen (HBO) therapy, alone or combined with the pentavalent antimonial 
glucantime on Leishmania amazonensis infection. In parallel, the effect of Brazilian red propolis gel (propain) alone or combined 
with glucantime on L. amazonensis infection was evaluated. The inhibition of the infection in macrophages treated with glucantime in 
combination with HBO exposition was greater than that of macrophages treated with glucantime alone or HBO alone. The susceptible 
mouse strain BALB/c infected in the shaved rump with L. amazonensis treated with glucantime and exposed to HBO showed: time 
points in the course of the disease in which lesions were smaller than those of mice treated with glucantime alone and revascularization 
of the skin in the lesion site; interferon-gamma (IFN-γ) levels were not elevated in lymph node cells from these animals. Propain alone 
was not efficient against lesions, although less exudative lesions were observed in animals treated with propain alone or combined with 
glucantime. These results reveal the potential value of HBO and red propolis in combination with glucantime for treating cutaneous 
leishmaniasis and encourage further studies on the effect of more aggressive HBO, propolis and glucantime therapies on different 
mouse models of leishmaniasis.
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INTRODUCTION
Leishmaniasis is a neglected disease caused by a protozoan of 
the genus Leishmania; it is currently endemic in 88 countries11,25. The 
severity of the disease induced by different Leishmania species varies 
enormously, ranging from cutaneous or mucosal to visceral or diffuse 
cutaneous infection15. Chemotherapy remains the mainstay for the 
control of leishmaniasis, as effective vaccines have yet to be developed16. 
The pentavalent antimonial (Sbv) glucantime has been the basis of 
leishmaniasis therapy worldwide for over 50 years, achieving remarkable 
clinical improvements, despite its failure to provide a parasitological 
cure and its side effects1,8.
In the search for new alternative therapies we have recently reported 
that hyperbaric oxygen (HBO) therapy, which is the application of 
pressures greater than 1 ATA to an environment of 100% O218, reduced 
the size of L. amazonensis-induced footpad lesions in BALB/c mice3, 
while Brazilian Northeastern red propolis tested as an extract was capable 
of reducing the parasite load in the in vitro L. amazonensis infection of 
macrophages4. Various compounds have been tested, combined with 
glucantime, in order to improve chemotherapy7,9,14,21-23,26,28,30,34, and the 
rationale behind combining drugs and therapies allows the reduction 
of treatment duration, resulting in fewer side effects and fewer delays 
in the development of resistance8,34. This report describes the effect 
of the combined therapy of HBO and glucantime against intracellular 
amastigotes in vitro and against infection in mouse model BALB/c. The 
activity of Brazilian red propolis gel and glucantime against infection 
in the BALB/c model was also evaluated. The choice of the mouse 
model infected with L. amazonensis in the shaved rump was due to its 
development of cutaneous lesion closely correspondent to the clinical 
setting which allows for topical application to the skin19.
MATERIALS AND METHODS
Mice: Inbred BALB/c mice, 6-8 weeks of age, were purchased for 
the mouse breeding facility at Universidade Estadual de Campinas, 
Campinas, Brazil. All animal experiments were conducted in accordance 
with institutional guidelines in compliance with the recommendations of 
the Guide for the Care and Use of Laboratory Animals. 
Parasite and infection of mice: L. amazonensis (MHOM/
BR/73/2269) amastigotes were isolated from skin lesions of susceptible 
mice as previously described3,6. BALB/c mice were infected with 1 X 
105 amastigotes suspended in 20-50 µL of sterile saline by subcutaneous 
injection into the shaved rump. Lesions were measured weekly in two 
perpendicular diameters with a dial caliper at weekly intervals19 and 
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were expressed by the dimensions of the nodule base (width by length). 
The mice were also regularly examined to detect cutaneous ulcers and 
secondary lesions.
Histological studies: Skin lesion tissues were fixed by immersion in 
4% paraformaldehyde in 0.1M PBS/0.1M sucrose for 6 h and processed 
for standard paraffin embedding3. Tissue sections (5 µm) were stained 
with haematoxylin and eosin (H&E) and checked for pathological 
changes under an optical microscope (Eclipse E800-Nikon).
Treatment of mice using hyperbaric oxygen and glucantime: 
Mice caged in groups of six were exposed to 100% O2 at a pressure 
of 2.5 ATA for one hour per day in a small animal hyperbaric chamber 
(Research Chamber, model HB 1300B, Sechrist, CA, USA). The chamber 
was pressurized and decompressed at the rate of 0.5ATA. Glucantime 
(N-methyl glucamine antimoniate; Aventis, SP, Brazil) at 27 mg Sb+5/
kg/day was injected via intraperitoneal once a day for 20 days after L. 
amazonensis inoculation.
Treatment of mice using red propolis and glucantime: Red 
propolis was collected in the state of Alagoas, Brazil5,33. The ethanolic 
extracts of propolis were prepared as described by AYRES et al.4. The 
red propolis (2.5%) gel containing protease (propain) and a protease gel 
without propolis as a control12 were used for epicutaneous applications 
in the lesions twice or three times a day for 20 days after L. amazonensis 
inoculation. Glucantime at 27 mg Sb+5/kg/day was injected via 
intraperitoneal once a day for 20 days after L. amazonensis inoculation.
Cytokine measurements: Inguinal lymph-nodes were excised from 
animals and single-cell suspensions prepared in Dulbecco-modified 
minimal essential medium (Sigma Chemical, USA) containing 10% fetal 
bovine serum and antibiotics. Cells were plated in triplicate in 24-well 
culture plates at 4×106/mL stimulated with 2.5 µg/mL Concanavalin A 
(Con A) (Sigma Chemical, USA) for 48 h at 37 oC with 5% CO2 in the 
atmosphere3. The levels of interferon-gamma (IFN-γ), and interleukin 
4 (IL-4) of the supernatants were determined by an enzyme-linked 
immunosorbent assay kit according to the manufacturer’s instructions 
(Biolegend, CA, USA).
Infection of macrophage cultures: Primary mouse macrophages 
were obtained from normal BALB/c mice by peritoneal lavage, cultured 
on 24-well plates containing glass coverslips of 13 mm diameter and 
infected with a sixfold excess of amastigotes as previously described2. 
After the infection period, the cultures were washed to remove 
extracellular parasites and then submitted to different treatments at 37 oC 
in 5% CO2 in air in a humidified incubator. For the infection evaluation 
(percentage of infected macrophages and number of amastigotes per 
macrophage), the cells on the coverslips were stained with Giemsa and 
examined by light microscopy at a magnification of 1,0002.
Statistical analyses: In vitro experiments were performed at least 
three times in triplicate wells. Two to three independent experiments, 
involving 6-7 mice per group, were performed to analyze drug efficacy. 
Statistical analyses were performed using the two-tailed Student’s t-test 
and Microcal Origin 6.0 (Microcal Software), p < 0.01 for in vitro 
experiments and p < 0.05 for in vivo experiments. A two-way ANOVA 
followed by the Bonferroni test was used to compare treatments in mice 
over time.
RESULTS
We first addressed the question of whether HBO leishmanicidal 
activity in an amastigote-macrophage model for L. amazonensis is 
potentiated in combination with glucantime. As shown in Figure 1 and 
recently for our group2 macrophage cultures exposed to HBO exhibit a 
significant reduction in the percentage of infected cells and the number 
of amastigotes per cell as opposed to macrophage cultures not exposed to 
HBO. The effect of glucantime on infected cells was similar to HBO (Fig. 
1). The inhibition of the number of amastigotes per macrophage reached 
66% in cells treated with glucantime in combination with exposure to 
HBO (2.1 ± 0.32 vs. 5.9 ± 0.9), which is slightly greater than that of either 
glucantime or HBO alone (3.9 ± 0.7 and. 4.2 ± 0.6) (Fig. 1).
The increase of glucantime’s leishmanicidal efficacy by combining 
glucantime with exposure to HBO was measured in experiments using 
the BALB/c model infected with L. amazonensis in the shaved rump. One 
hundred percent of mice had ulcerations after six weeks of infection and 
their lesions failed to heal. These lesions were elevated and expanded 
with central ulceration over the next 14 weeks. The treatments started 
Fig. 1 - Effect of HBO and glucantime on macrophages infected with L. amazonensis. The 
mouse peritoneal macrophages were infected with amastigotes and cultured for 24 h (Control), 
treated with glucantime (6 µg Sb+5/mL) for 24 h (Gluca), exposed to HBO (2.5 ATA, 100% 
O2) for 2 h and then cultured for 22 h (HBO) or exposed to HBO for 2 h and then treated with 
glucantime (6 µg Sb+5/mL) for 22 h (Gluca+HBO). A. Percentage of infected macrophages. 
B. Number of intracellular amastigotes per macrophage. The results represent the mean ± 
SD of three experiments. * represents statistical differences (p < 0.01) between Control, 
Gluca and HBO. ** represents statistical differences (p < 0.01) between Gluca, HBO and 
Gluca+HBO.
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six weeks after infection when skin lesion ulcerated and continued for 
20 days. As shown in Figure 2, lesions progressively increased in size 
in untreated mice. Interestingly, HBO treatment, although relatively 
effective in the BALB/c model infected with L. amazonensis in the 
footpad3 (data not shown), was not active in this mouse model infected in 
the shaved rump (Fig. 2). In comparison, in mice treated with glucantime 
the lesions did not enlarge during the period of therapy; in fact, they were 
smaller after the end of therapy and ulceration developed slowly (Fig. 
2). In the case of animals treated with both glucantime and exposure to 
HBO, lesions also did not enlarge during the period of therapy. Although 
lesion size did not differ over time among animals both treated with 
glucantime and exposed to HBO and animals treated with glucantime 
alone, there are points in the course of the disease in which significant 
differences between lesion size and external appearance were observed 
(nine to 12 weeks after infection; Figs. 2 and 4).
We also investigated whether the efficacy of glucantime treatment 
is potentiated by gel containing red propolis (propain). After lesions 
were established (six weeks) animals were treated for 20 days with 
glucantime and/or the epicutaneous application of propain. Figure 3 
shows that, in mice treated with propain alone, lesions progressively 
enlarged, similar to lesions of untreated mice. In contrast, glucantime 
prevented lesion growth during and immediately (two weeks) after 
treatment, and ulceration developed slowly. The treatment with 
glucantime and propain prevented lesion development, although 
ulceration restarted slowly. No significant difference was found in 
lesion size among animals treated with both glucantime and propain 
and animals treated with glucantime alone. Interestingly, in mice treated 
topically with both propain and glucantime, lesions were less exudative 
than those in non-treated or glucantime treated mice, during the time 
of observation in the course of the infection (14 weeks). It should be 
noted that the topical preparation of propain did not elicit apparent 
toxicity; the skin was not irritated or inflamed and the surrounding 
skin did not lose hair.
Histopathological analyses revealed that in the lesions of untreated 
mice there was no epithelial tissue in the center of the ulcer and the 
cellular infiltrate consisted predominantly of parasitized and vacuolated 
macrophages (Fig. 4A and 4B). In contrast, lesions from mice treated with 
glucantime presented tissue reorganization involving the restructuring 
of epithelial tissue. There were very few infected macrophages and 
fewer infiltrating cells than in lesions of untreated mice (Fig. 4C and 
4D). After exposure of the lesions to HBO, the histological pattern was 
similar to that described for lesions of untreated mice (Fig. 4E and 4F), 
although a process of revascularization of skin took place in the lesion 
site (Fig. 4F). The lesions of animals both treated with glucantime and 
exposed to HBO presented a pattern similar to that of lesions of mice 
treated with glucantime alone and a process of revascularization of skin 
(Fig. 4L and 4M). The lesions of animals treated with glucantime and 
epicutaneous application of propain presented tissue reorganization, 
intact pilous follicles and skin glands, and few infected macrophages; a 
pattern similar to that of lesions in mice treated with glucantime alone 
(Fig. 4G and 4H). The lesions of animals treated with the epicutaneous 
application of propain alone presented a pattern similar to that of lesions 
in untreated mice (Fig. 4I and 4J).
To analyze whether the therapies tested induce immune responses, 
we measured the levels of IFN-γ and IL-4 production by ConA-
stimulated lymph node cells. It was observed that infected untreated 
mice produced higher levels of IFN-γ compared to mice treated with 
glucantime alone or treated with both glucantime and exposure to HBO 
(8,200 ± 250 vs. 1,059 ± 145 vs. 100 ± 31; Fig. 5). It was observed 
that mice treated with both glucantime and propain produced higher 
levels of IFN-γ than mice treated with glucantime alone (3,090 ± 122 
versus 1,059 ± 145; Fig. 5). No detectable levels of IL-4 were found 
in cell cultures of mice untreated or treated with glucantime, propain 
or exposed to HBO (data not shown).
Fig. 2 - Effect of HBO and glucantime on lesion development in BALB/c mice infected with 
L. amazonensis. Animals were inoculated in the shaved rump with 1X105 amastigotes. After 
six weeks of infection, mice were treated intraperitoneally with saline (), glucantime (27 
mg/Sb+5/kg/day) (), exposed to HBO (2.5 ATA, 100% O2, 1h/day) () or exposed to HBO 
and treated with glucantime (27 mg/Sb+5/kg/day) () for 20 days. Representative data from 
one of three experiments are shown. * represent statistical differences (p < 0.05) between 
saline, glucantime and glucantime + HBO. ** represent statistical differences (p < 0.05) 
between glucantime and glucantime + HBO. Arrows indicate the beginning and end of the 
treatments.
Fig. 3 - . Effect of propain and glucantime on lesion development in BALB/c mice infected 
with L. amazonensis. Animals were inoculated into the shaved rump with 1X105 amastigotes. 
After six weeks of infection, mice were treated topically with propain (), gel without propolis 
(), intraperitoneally with glucantime (27 mg/Sb+5/kg/day) () or glucantime (27 mg/Sb+5/kg/
day) + propain (), for 20 days. The results represent the mean ± SD of three experiments. * 
represents statistical differences (p < 0.05) between propain, gel without propolis + glucantime 
and glucantime + propain. Arrows indicate the beginning and end of the treatments.
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DISCUSSION
The combination of chemotherapy for treatment of leishmaniasis and 
other infectious diseases has been addressed in latter years7,9,14,21-23,26,30,32,34. 
Recently, we showed that HBO is toxic for L. amazonensis promastigotes 
and can reduce macrophage susceptibility to infection and the size of 
footpad lesion in BALB/c mice2,3. In the present study, the inhibition of 
the infection in macrophages treated with glucantime in combination with 
HBO was greater than that of macrophages treated with glucantime alone 
and HBO alone. The exact mechanism by which glucantime combined 
with HBO was more effective in the in vitro macrophage model is not 
known. Based on our previous reports2 and literature data10,13 we suggest 
that free radicals and other reactive oxygen-based molecules produced by 
macrophages and parasites under HBO cannot be adequately detoxified 
by parasites treated simultaneously with glucantime. Antimonials 
inhibit trypanothione reductase enzymatic system, which protect against 
oxidative damage13.
The in vivo model studies showed that there are points in the 
course of the disease in BALB/c mice treated with both glucantime 
and exposure to HBO in which lesions are smaller than those in mice 
treated with glucantime alone. This may be an indicator that HBO is 
having a small but significant impact in improving glucantime efficacy. 
Indeed, animals exposed to HBO exhibited skin revascularization in the 
lesion site which could facilitate glucantime delivery. Previous reports 
have shown in wound mouse models27,31, transplanted rats31, and rat 
liver after partial hepatectomy17 that neovascularization is increased 
in animals exposed to HBO. To analyze whether the therapies induce 
immune responses, INF-γ and IL-4 levels were measured. The INF-γ 
level produced by ConA-stimulated draining lymph node cells of 
infected mice is as high as that also reported by BARROSO et al.7, but 
a reduction of INF-γ was observed in animals treated with glucantime, 
which is attributed to the inhibition of the parasite burden in lesions, 
i.e. the source of INF-γ stimulus7,24. Interestingly, a marked-down 
regulation of INF-γ was also observed when mice were both treated 
with glucantime and exposed to HBO; which also could be related to 
the reduction of parasites in the lesions.
The other objective of this study was to evaluate the activity of red 
propolis combined with glucantime treatment. Once we had already 
Fig. 4 - Photomicrographs of skin lesions in BALB/c mice infected with L. amazonensis 
and treated with both glucantime and exposure to HBO. After 10 weeks of infection, 
histopathological examination revealed no epithelium tissue and many parasitized 
macrophages in the lesions of untreated mice, X20 (A) and X100 (B); tissue organization and 
very few infected macrophages in the lesions of mice treated with glucantime, X20 (C) and 
X100 (D); pathologic alterations observed in the lesions of mice exposed to HBO, X20 (E) 
and X100 (F) were similar to those observed in the lesions of untreated mice. Inset show blood 
vessels. Tissue organization and very few infected macrophages are shown in the lesions of 
mice treated with both propain and glucantime, X20 (G) and X100 (H) or treated with propain 
alone, X20 (I) and X100 (J). Insets show parasitized macrophages. Tissue organization in the 
lesions of mice both exposed to HBO and treated with glucantime, X20 (L) and X100 (M).
Fig. 5 - INF-γ production in BALB/c mice infected with L. amazonensis and treated with 
glucantime, propain or exposure to HBO. Supernatants from ConA-stimulated draining of 
lymph node cells from untreated mice (Control), treated with glucantime (Gluca), glucantime 
and exposure to HBO (Gluca+HBO) or glucantime and propain (Gluca+Prop) were assayed 
by INF-γ production by ELISA. The results represent the mean ± SD of independent repeats. 
* represents statistical differences (p < 0.01) between the Control and Gluca, Gluca+HBO 
and Gluca+Prop.
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shown the anti-parasite effect of ethanolic extracts of red propolis in 
promastigotes and in L. amazonensis infected macrophages4, we tested 
red propolis gel (propain) on mouse model BALB/c. The treatment with 
both propain and glucantime was similar to the treatment with glucantime 
alone, i.e. lesion growth is prevented for two weeks after treatment 
and smaller lesions than those in untreated mice are present until the 
end of the experiment. However, less exudative lesions were observed 
in animals treated with propain alone or combined with glucantime. 
Propain alone was not effective against L. amazonensis lesions. Various 
pharmacological effects have been attributed to propolis, such as antiviral, 
antibacterial and analgesic29,33 effects. The red propolis extract studied 
in this report reduced the dissemination of melanoma cells in mice12. 
The reasons for our results are not known. BALB/c mice cutaneously 
infected with L. amazonensis represent a model of extreme susceptibility 
and a string test for chemotherapy displaying rapid development of skin 
lesions followed by ulceration and cutaneous metastases resembling 
human cutaneous diffuse leishmaniasis. No cure was obtained with 
glucantime6,20.
In conclusion, the results presented in this report reveal the potential 
value of HBO and red propolis in combination with glucantime for 
treating cutaneous leishmaniasis and encourage further studies on the 
effects of more-aggressive HBO, propolis and glucantime therapies in 
different mouse models of leishmaniasis.
RESUMO
A utilidade da terapia de oxigenação hiperbárica e própolis em 
potencializar a atividade leishmanicida do glucantime
Nesse trabalho foi avaliada a eficácia da terapia da oxigenação 
hiperbárica (HBO), aplicada em combinação ou não com o tratamento 
com glucantime, durante a infecção com Leishmania amazonensis. 
O efeito de gel da própolis vermelha de origem brasileira (propaina) 
aplicado em combinação ou não com o tratamento com glucantime, 
também foi avaliado durante infecção com esse parasita. A inibição da 
infecção de macrófagos tratados com glucantime em combinação com 
HBO foi maior que a de macrófagos tratados apenas com glucantime 
ou HBO. A linhagem murina susceptível, BALB/c, infectada no dorso 
com L. amazonensis, tratada com glucantime e exposta a HBO, mostrou 
durante o curso da doença, fases em que as lesões eram menores do 
que a de camundongos apenas tratados com glucantime; observou-se 
revascularização da pele da lesão e baixa produção de interferon-gama 
em células de linfonodos desses animais. O tratamento com propaina não 
foi eficiente na cura das lesões, apesar de lesões menos exsudativas serem 
observadas em animais tratados com propaina ou propaina combinada 
ao tratamento com glucantime. Os resultados demonstram que tanto 
HBO como a própolis vermelha em combinação com glucantime, são 
promissoras no tratamento da leishmaniose cutânea. Novos estudos 
devem ser realizados para avaliar tratamentos e outros protocolos em 
diferentes modelos murinos da leishmaniose. 
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